145 related articles for article (PubMed ID: 34525371)
21. Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive "low footprint" genetic knockout of alpha-synuclein.
Goloborshcheva VV; Chaprov KD; Teterina EV; Ovchinnikov R; Buchman VL
Mol Brain; 2020 May; 13(1):75. PubMed ID: 32393371
[TBL] [Abstract][Full Text] [Related]
22. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.
Lieberman OJ; Choi SJ; Kanter E; Saverchenko A; Frier MD; Fiore GM; Wu M; Kondapalli J; Zampese E; Surmeier DJ; Sulzer D; Mosharov EV
eNeuro; 2017; 4(6):. PubMed ID: 29177188
[TBL] [Abstract][Full Text] [Related]
23. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.
Oosterveen T; Garção P; Moles-Garcia E; Soleilhavoup C; Travaglio M; Sheraz S; Peltrini R; Patrick K; Labas V; Combes-Soia L; Marklund U; Hohenstein P; Panman L
Stem Cell Reports; 2021 Nov; 16(11):2718-2735. PubMed ID: 34678205
[TBL] [Abstract][Full Text] [Related]
24. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.
Chung SY; Kishinevsky S; Mazzulli JR; Graziotto J; Mrejeru A; Mosharov EV; Puspita L; Valiulahi P; Sulzer D; Milner TA; Taldone T; Krainc D; Studer L; Shim JW
Stem Cell Reports; 2016 Oct; 7(4):664-677. PubMed ID: 27641647
[TBL] [Abstract][Full Text] [Related]
25. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
[TBL] [Abstract][Full Text] [Related]
26. Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1.
Lin X; Parisiadou L; Sgobio C; Liu G; Yu J; Sun L; Shim H; Gu XL; Luo J; Long CX; Ding J; Mateo Y; Sullivan PH; Wu LG; Goldstein DS; Lovinger D; Cai H
J Neurosci; 2012 Jul; 32(27):9248-64. PubMed ID: 22764233
[TBL] [Abstract][Full Text] [Related]
27. FOXO3 determines the accumulation of α-synuclein and controls the fate of dopaminergic neurons in the substantia nigra.
Pino E; Amamoto R; Zheng L; Cacquevel M; Sarria JC; Knott GW; Schneider BL
Hum Mol Genet; 2014 Mar; 23(6):1435-52. PubMed ID: 24158851
[TBL] [Abstract][Full Text] [Related]
28. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.
Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I
Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287
[TBL] [Abstract][Full Text] [Related]
29. Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra.
Hong J; Wang L; Zhang T; Zhang B; Chen L
Neurobiol Aging; 2017 Nov; 59():171-183. PubMed ID: 28870519
[TBL] [Abstract][Full Text] [Related]
30. Homogenous generation of dopaminergic neurons from multiple hiPSC lines by transient expression of transcription factors.
Mahajani S; Raina A; Fokken C; Kügler S; Bähr M
Cell Death Dis; 2019 Nov; 10(12):898. PubMed ID: 31776327
[TBL] [Abstract][Full Text] [Related]
31. Mutant α-synuclein enhances firing frequencies in dopamine substantia nigra neurons by oxidative impairment of A-type potassium channels.
Subramaniam M; Althof D; Gispert S; Schwenk J; Auburger G; Kulik A; Fakler B; Roeper J
J Neurosci; 2014 Oct; 34(41):13586-99. PubMed ID: 25297088
[TBL] [Abstract][Full Text] [Related]
32. Sox6 and Otx2 control the specification of substantia nigra and ventral tegmental area dopamine neurons.
Panman L; Papathanou M; Laguna A; Oosterveen T; Volakakis N; Acampora D; Kurtsdotter I; Yoshitake T; Kehr J; Joodmardi E; Muhr J; Simeone A; Ericson J; Perlmann T
Cell Rep; 2014 Aug; 8(4):1018-25. PubMed ID: 25127144
[TBL] [Abstract][Full Text] [Related]
33. A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice.
Zhang J; Götz S; Vogt Weisenhorn DM; Simeone A; Wurst W; Prakash N
Neurobiol Dis; 2015 Oct; 82():32-45. PubMed ID: 26049140
[TBL] [Abstract][Full Text] [Related]
34. Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice.
Pavia-Collado R; Rodríguez-Aller R; Alarcón-Arís D; Miquel-Rio L; Ruiz-Bronchal E; Paz V; Campa L; Galofré M; Sgambato V; Bortolozzi A
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163729
[TBL] [Abstract][Full Text] [Related]
35. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
[TBL] [Abstract][Full Text] [Related]
36. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons.
Xue Y; Zhan X; Sun S; Karuppagounder SS; Xia S; Dawson VL; Dawson TM; Laterra J; Zhang J; Ying M
Stem Cells Transl Med; 2019 Feb; 8(2):112-123. PubMed ID: 30387318
[TBL] [Abstract][Full Text] [Related]
37. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
38. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
Coune PG; Bensadoun JC; Aebischer P; Schneider BL
J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
[TBL] [Abstract][Full Text] [Related]
39. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
[TBL] [Abstract][Full Text] [Related]
40. The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease.
Michell AW; Tofaris GK; Gossage H; Tyers P; Spillantini MG; Barker RA
Cell Transplant; 2007; 16(5):461-74. PubMed ID: 17708336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
